InsiderTrades

Form 4 for ANIK Anika Therapeutics, Inc.

Accepted 2023-08-11 00:00:00 ET · period of report 2023-08-10 · accession 0001171843-23-005271 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-08-11 2023-08-10 ANIK Levitz Michael L EVP, CFO, Treas F - Tax $18.58 -1,133 33.2K -3% -$21.1K
D 2023-08-11 2023-08-10 ANIK Levitz Michael L EVP, CFO, Treas M - OptEx $0.00 +3,859 34.4K +13% $0
D 2023-08-11 2023-08-10 ANIK Levitz Michael L EVP, CFO, Treas M - OptEx $0.00 -3,859 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-08-10 F D 1,133 $18.58 33,232 D — — (F3) Reflects an aggregate of 1,133 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on August 10, 2023. (F4) Reflects the closing price of ANIK common stock on August 10, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
2 Common Common Stock 2023-08-10 M A 3,859 $0.00 34,365 D — — (F1) Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on August 10, 2020. (F2) Includes 668 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 12, 2023.
3 Derivative Restricted Stock Unit 2023-08-10 M D 3,859 $0.00 0 D $0.00 · — to — 3,859 Common Stock (F5) Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning August 10, 2021.